FCF Yield
Updated 152h ago
Sector Performance
69th percentileCBOE
6.0%
Sector Median
4.2%
Sector Avg
7.7%
Deep Analysis
CBOE’s current free cash flow (FCF) yield of 6.0% means that for every $100 of its market value, the company generated $6.00 in free cash flow last year — a measure of how much cash remains after capital spending, often used to gauge how cheaply a stock generates cash.
This yield sits above the sector median of 4.2%, placing CBOE in the 70th percentile among its peers, indicating a relatively higher cash return compared to the typical competitor. The year-over-year change is not available, but the quarter-over-quarter shift shows an increase of 36.4% from the prior quarter’s 4.4% to the current 6.0%. A yield above the sector median combined with a strong recent quarterly improvement suggests the stock is becoming more attractive from a valuation standpoint, though the limited historical data points temper the signal. This metric supports the overall NEUTRAL verdict — the yield is above average and improving, but not at a level that alone justifies a bullish call given the lack of long-term trend evidence.
Frequently Asked Questions
What does the FCF Yield tell investors about CBOE?
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
How is the FCF Yield calculated?
FCF Yield is calculated as: Free Cash Flow / Market Cap.
Who are CBOE's closest peers by FCF Yield?
The closest peers by FCF Yield include: FMC (-12.9%), NCLH (-13.0%), XEL (-13.6%), SG (-13.6%), GS (-14.0%).
The Formula
Free Cash Flow / Market Cap
Why It Matters
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
Master CBOE's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CBOE research report →CBOE
6.0%
Sector Median
4.2%
Sector Avg
7.7%
How CBOE's FCF Yield compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.